Negative Pressure Wound Therapy Market Will Reach $4.0 Billion By 2025: Grand View Research, Inc.

The global negative pressure wound therapy (NPWT) market is anticipated to reach a value of USD 4.0 billion by 2025, according to a new report by Grand View Research, Inc. Increasing awareness in the developing regions pertaining to advanced wound care is providing a significant opportunity to the key market players to cater to the unmet needs of the target population. The primary driver associated with this market is the cost-effectiveness of single-use negative pressure wound therapy devices.

Major companies are also focusing on education of reimbursement coveragein such regions to further increase the affordability of these devices. However, the current reimbursement policies mostly cover conventional NPWT devices owing to their high cost.Furthermore, the geriatric population is also contributing to a great extent toward increasing the prevalence of chronic diseases. Increasing age is one of the high risk factorsleading to the development of chronic diseases such as atherosclerosis, which is one of the prime cardiovascular disorders prevalent in the geriatric population.

NPWT is one of the commonly accepted therapies employed for the treatment of arterial ulcers, which is one of the major complications of atherosclerosis. Around 50% of the people worldwide are exposed to fire-related traumas, among which, 90% of the cases occur in low to moderate income countries.Thus, the rising incidence of traumatic events is expected toengender a high demand for negative pressure wound therapy products.

Browse full research report on Negative Pressure Wound Therapy Market: http://www.grandviewresearch.com/industry-analysis/negative-pressure-wound-therapy-npwt-market   

Further Key Findings from the Study Suggest:

  • Conventional NPWT devices dominated the product segment in 2015 owing to their high cost and availability of favorable reimbursement policies
  • Single-use negative pressure wound therapy devices segment is considered to be the fastest growing segment over the forecast period
  • Diabetic foot ulcer held the largest revenue share in 2015 owing to its numerous applications,thus yielding a high success rate using NPWT
  • Homecare setting is anticipated to witness an attractive CAGR over the forecast period owing to the emerging applicability of single-use NPWT devices in the homecare setting and cost-effectiveness of the therapy
  • North America dominated the overall NPWT market in 2015. This is primarily due to the increased usage of the target therapy in this region, which has led to a reduction in hospital stays and contributed toward enhanced quality of patient lives
  • Some key companies in this market are Acelity L.P. Inc., Smith & Nephew, Mölnlycke Health Care, Talley Group Limited, ConvaTec Inc., Devon Medical, Cardinal Health, Inc., DeRoyal Industries, Inc., Medela AG and Paul Hartmann AG
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the negative pressure wound therapy market on the basis of product, wound type, end use, and region:

Global Product Outlook (Revenue, USD Million; 2014 - 2025)
  • Conventional NPWT
  • Single-use NPWT
Global Type Outlook (Revenue, USD Million; 2014 - 2025)
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Pressure Ulcers
  • Burn Wounds
  • Others
Global End Use Outlook (Revenue, USD Million; 2014 - 2025)
  • Hospitals
  • Homecare
  • Others
Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-negative-pressure-wound-therapy-npwt-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc


For more information: www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more